Premium
Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long‐term follow‐up of a prospective study
Author(s) -
Gandhi Maher K.,
Lekamwasam Sarath,
Inman Ingrid,
Kaptoge Stephen,
Sizer Lorraine,
Love Shirley,
Bearcroft Philip W.,
Milligan Thomas P.,
Price Christopher P.,
Marcus Robert E.,
Compston Juliet E.
Publication year - 2003
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2003.04303.x
Subject(s) - medicine , femoral neck , bone mineral , surgery , transplantation , bone density , prospective cohort study , bone remodeling , hematopoietic stem cell transplantation , urology , osteoporosis
Summary. Reduced bone mineral density (BMD) has been reported following allogeneic stem cell transplantation (alloSCT) but the effects of autologous SCT (autoSCT) are less well characterized. We performed a prospective study of BMD changes and its determinants in 44 SCT recipients (38 auto and six allo; 30 peripheral blood SCT and 14 bone marrow transplantation). Serial measurements of BMD at the lumbar spine and femoral neck were performed at baseline and at 3, 6, 12 and 24 months, and spinal radiographs were performed at baseline and 12 months. Mean baseline BMD values at the femoral neck and spine were within normal limits. At 3 months, there was a significant decline of BMD at the femoral neck ( P = 0·011) and a non‐significant trend towards reduction at the spine. BMD loss persisted for up to 2 years at the femoral neck ( P = 0·005), but values returned to baseline at the spine. Reflecting the rapid initial decline in BMD, bone‐specific alkaline phosphatase (a serum marker of bone formation) showed a significant initial decline at 1 month but had recovered to pretransplant levels by 3 months. No new fractures were detected at 1 year post transplant. Sex, diagnosis, use of total body irradiation, stem cell source and type of graft (auto versus allo) did not significantly predict BMD change over the first 12 months. In conclusion, significant and persistent bone loss at the femoral neck was demonstrated in this group of patients following stem cell transplantation. The implications of these findings for future fracture risk require further study.